Indeed, interleukin-10 (IL-10), tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), advanced oxidation protein products and nitric oxide metabolites (NOx) were significantly higher in MS patients with a higher EDSS [68]. This evidence concerns the gene TNF and myeloid sarcoma.